These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Electrophilic fatty acids impair RAD51 function and potentiate the effects of DNA-damaging agents on growth of triple-negative breast cells. Asan A; Skoko JJ; Woodcock CC; Wingert BM; Woodcock SR; Normolle D; Huang Y; Stark JM; Camacho CJ; Freeman BA; Neumann CA J Biol Chem; 2019 Jan; 294(2):397-404. PubMed ID: 30478172 [TBL] [Abstract][Full Text] [Related]
3. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals. Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733 [TBL] [Abstract][Full Text] [Related]
4. Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF-κB signals. Chen ZJ; Wei W; Jiang GM; Liu H; Wei WD; Yang X; Wu YM; Liu H; Wong CK; Du J; Wang HS Mol Oncol; 2016 Jun; 10(6):775-88. PubMed ID: 26842883 [TBL] [Abstract][Full Text] [Related]
5. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer. Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A Front Immunol; 2019; 10():804. PubMed ID: 31105691 [TBL] [Abstract][Full Text] [Related]
6. Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways. Singel SM; Batten K; Cornelius C; Jia G; Fasciani G; Barron SL; Wright WE; Shay JW Breast Cancer Res; 2014 Mar; 16(2):R28. PubMed ID: 24642040 [TBL] [Abstract][Full Text] [Related]
7. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells. Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795 [TBL] [Abstract][Full Text] [Related]
8. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway. Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829 [TBL] [Abstract][Full Text] [Related]
9. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
10. Alcohol promotes migration and invasion of triple-negative breast cancer cells through activation of p38 MAPK and JNK. Zhao M; Howard EW; Parris AB; Guo Z; Zhao Q; Yang X Mol Carcinog; 2017 Mar; 56(3):849-862. PubMed ID: 27533114 [TBL] [Abstract][Full Text] [Related]
11. PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis. Paul A; Gunewardena S; Stecklein SR; Saha B; Parelkar N; Danley M; Rajendran G; Home P; Ray S; Jokar I; Vielhauer GA; Jensen RA; Tawfik O; Paul S Cell Death Differ; 2014 Sep; 21(9):1469-81. PubMed ID: 24786829 [TBL] [Abstract][Full Text] [Related]
12. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer. Kabil N; Bayraktar R; Kahraman N; Mokhlis HA; Calin GA; Lopez-Berestein G; Ozpolat B Breast Cancer Res Treat; 2018 Oct; 171(3):593-605. PubMed ID: 29971628 [TBL] [Abstract][Full Text] [Related]
13. CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation. Wright HJ; Hou J; Xu B; Cortez M; Potma EO; Tromberg BJ; Razorenova OV Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6556-E6565. PubMed ID: 28739932 [TBL] [Abstract][Full Text] [Related]
14. Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis. Yang HL; Thiyagarajan V; Shen PC; Mathew DC; Lin KY; Liao JW; Hseu YC J Exp Clin Cancer Res; 2019 May; 38(1):186. PubMed ID: 31068208 [TBL] [Abstract][Full Text] [Related]
15. A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer. D'Amato NC; Rogers TJ; Gordon MA; Greene LI; Cochrane DR; Spoelstra NS; Nemkov TG; D'Alessandro A; Hansen KC; Richer JK Cancer Res; 2015 Nov; 75(21):4651-64. PubMed ID: 26363006 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin. Wu YM; Chen ZJ; Liu H; Wei WD; Lu LL; Yang XL; Liang WT; Liu T; Liu HL; Du J; Wang HS Oncotarget; 2015 Sep; 6(28):25588-601. PubMed ID: 26160845 [TBL] [Abstract][Full Text] [Related]
17. Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability. Powell CA; Nasser MW; Zhao H; Wochna JC; Zhang X; Shapiro C; Shilo K; Ganju RK Oncotarget; 2015 Mar; 6(8):6373-85. PubMed ID: 25779666 [TBL] [Abstract][Full Text] [Related]
18. Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin β1/ Src signaling in triple negative breast cancer cells. Hamurcu Z; Delibaşı N; Geçene S; Şener EF; Dönmez-Altuntaş H; Özkul Y; Canatan H; Ozpolat B J Cancer Res Clin Oncol; 2018 Mar; 144(3):415-430. PubMed ID: 29288363 [TBL] [Abstract][Full Text] [Related]
19. Tryptophan hydroxylase 1 and 5-HT Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326 [TBL] [Abstract][Full Text] [Related]
20. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells. Hamurcu Z; Ashour A; Kahraman N; Ozpolat B Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]